Specify a stock or a cryptocurrency in the search bar to get a summary
Isofol Medical AB
ISOFOLIsofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. Address: Biotech Center, Gothenburg, Sweden, 413 46
Analytics
WallStreet Target Price
14.39 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ISOFOL
Dividend Analytics ISOFOL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ISOFOL
Stock Valuation ISOFOL
Financials ISOFOL
Results | 2019 | Dynamics |